Thrombelastography and sepsis
- PMID: 17466081
- PMCID: PMC2206445
- DOI: 10.1186/cc5712
Thrombelastography and sepsis
Comment on
-
Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis.Crit Care. 2006;10(6):R160. doi: 10.1186/cc5098. Crit Care. 2006. PMID: 17107615 Free PMC article. Clinical Trial.
References
-
- Haemoscope Corporation . TEG Hemostasis Analyzer User Manual. Niles, IL: Haemoscope Corporation; 1999.
-
- Grant HW, Hadley GP. Prediction of neonatal sepsis by thrombelastography. Pediatr Surg Int. 1997;12:289–292. - PubMed
-
- Nates JL, Doursout MF, Weavind L, Chelly JE. A thrombelastographic study of lipopolysaccharide induced coagulation abnormalities in a pig endotoxemic shock model. Crit Care Med. 1999;27:A102. doi: 10.1097/00003246-199912001-00274. - DOI
-
- Kienast J, Juers M, Wiedermann CJ, Hoffmann JN, Ostermann H, Strauss R, Keinecke HO, Warren BL, Opal SM. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost. 2006;4:90–97. doi: 10.1111/j.1538-7836.2005.01697.x. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
